1198-27-2

应用筛选条件

关键词:'1198-27-2'

显示 1-1 共 1 条结果关于 "1198-27-2" 范围论文

Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial.

Matthew T Seymour et al.

The Lancet. Oncology, 14(8), 749-759 (2013-06-04)

Therapeutic antibodies targeting EGFR have activity in advanced colorectal cancer, but results from clinical trials are inconsistent and the population in which most benefit is derived is uncertain. Our aim was to assess the addition of panitumumab to irinotecan in

1/1